Multimodality cardiovascular imaging is transforming clinical trials by enhancing precision medicine through complementary insights from CT, MRI, echocardiography, and nuclear imaging. It enables early disease detection, stratified patient selection, and surrogate endpoints, improving trial efficiency and outcomes. A case study on amyloidosis shows how combining imaging techniques offers non-invasive diagnosis, amyloid subtyping, and treatment monitoring. Standardization through core labs, working groups, and protocols ensures data quality, consistency, and regulatory compliance. Medpace Core Labs supports these efforts with expertise, AI tools, and integrated infrastructure to streamline complex imaging trials.

Join for free to read